Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Surgical Science Sweden AB
F:4P41
Surgical Science Sweden AB
F:4P41
Price:
4.626
EUR
0.74%
Market Closed
Market Cap:
€236m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Surgical Science Sweden AB
F:4P41
|
SE |
|
Oracle Power PLC
F:9OC
|
UK |
|
Cyberoo SpA
F:K97
|
IT |
|
R8 Capital Investments PLC
F:MOC
|
UK |
|
3P Learning Ltd
F:73P
|
AU |
|
Belite Bio Inc
NASDAQ:BLTE
|
US |
|
C
|
Craftport Cannabis Corp
CNSX:CFT
|
CA |
|
S
|
SciDev Ltd
F:INFA
|
AU |
|
M
|
Minco Silver Corp
XMUN:XYD
|
CA |
Wall St Price Targets
4P41 Price Forecast
Based on 6 analysts
Based on 6 analysts
+115% Upside
from
€4.626
today
Surgical Science Sweden AB (4P41)’s 12-month stock price forecast through October 2027 has a consensus target of €9.949, implying 115% upside. The forecast is based on price targets from 6 Wall Street analysts.
4P41 Analyst Rating
No ratings yet
No ratings yet
Surgical Science Sweden AB Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4P41's stock price target?
Price Target
9.949
EUR
9.949
EUR
According to Wall Street analysts, the average 1-year price target for 4P41 is 9.949 EUR with a low forecast of 9.611 EUR and a high forecast of 14.821 EUR.
What is the Revenue forecast for Surgical Science Sweden AB?
Projected CAGR
10%
10%
Over the last 10 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 8 years is 10%.
What is the Gross Profit forecast for Surgical Science Sweden AB?
Projected CAGR
12%
12%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 29%. The projected CAGR for the next 5 years is 12%.
What is the Operating Income forecast for Surgical Science Sweden AB?
Projected CAGR
30%
30%
Over the last 10 years, the compound annual growth rate for Operating Income has been 49%. The projected CAGR for the next 5 years is 30%.
What is the Pre-Tax Income forecast for Surgical Science Sweden AB?
Projected CAGR
34%
34%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 51%. The projected CAGR for the next 3 years is 34%.
What is the Net Income forecast for Surgical Science Sweden AB?
Projected CAGR
36%
36%
Over the last 10 years, the compound annual growth rate for Net Income has been 45%. The projected CAGR for the next 5 years is 36%.